Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Change in Account Payables (2024 - 2025)

Carlsmed's Change in Account Payables history spans 2 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 406.54% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.7 million, changed N/A, while the annual FY2025 figure was $2.3 million, 682.15% up from the prior year.
  • Change in Account Payables reached $1.6 million in Q4 2025 per CARL's latest filing, up from $682000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.6 million in Q4 2025 to a low of -$535000.0 in Q4 2024.